Genetic Analysis AS (XSAT:GEAN)
Sweden · Delayed Price · Currency is SEK · Price in NOK 0.7950
0.00 (0.00%)
At close: Nov 7, 2025
Genetic Analysis AS Market Cap
Genetic Analysis AS has a market cap or net worth of 51.54 million as of November 7, 2025. Its market cap has increased by 48.21% in one year.
Market Cap
51.54M
Enterprise Value
35.11M
Revenue
20.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.80
Market Cap Chart
Since October 1, 2021, Genetic Analysis AS's market cap has decreased from 235.48M to 51.54M, a decrease of -78.11%. That is a compound annual growth rate of -30.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 51.54M | 110.72% |
| Dec 30, 2024 | 24.46M | -31.37% |
| Dec 29, 2023 | 35.64M | -34.69% |
| Dec 30, 2022 | 54.57M | -66.71% |
| Dec 30, 2021 | 163.91M | -30.39% |
| Oct 1, 2021 | 235.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Investor AB | 954.97B |
| Atlas Copco AB | 730.15B |
| AB Volvo | 530.89B |
| ASSA ABLOY AB | 394.55B |
| EQT AB | 373.87B |
| Sandvik AB | 358.50B |
| Skandinaviska Enskilda Banken AB | 357.08B |
| Swedbank AB | 325.58B |